Skip to content
Open access

NRP1 silencing induces ROS-mediated cell cycle arrest and mitochondrial apoptosis in non-small cell lung cancer via upregulation of AGER

Jan 2026 · Clinics · Vol 81 · 0 citations · 25 references
Medicine

TL;DR

NRP1 is significantly upregulated, whereas AGER is downregulated in NSCLC tissues, and the NRP1–AGER axis regulates oxidative stress–mediated tumor progression in NSCLC.

Abstract

Highlights • NRP1 is significantly upregulated, whereas AGER is downregulated in NSCLC tissues.• Silencing NRP1 inhibits NSCLC cell proliferation and induces G1 phase arrest.• NRP1 knockdown triggers mitochondria-dependentk apoptosis and ROS accumulation.• AGER overexpression suppresses cell growth and mimics the effects of NRP1 silencing.• The NRP1–AGER axis regulates oxidative stress–mediated tumor progression in NSCLC.

Read PDF

Similar papers

Open access Aug 2026

STT3 promotes cervical cancer proliferation and apoptosis via PI3K/AKT pathway

Highlights • Cervical carcinoma tissues exhibit elevated expression of STTA and STT3B, with this overexpression significantly correlated with poor patient prognosis.• Knockdown of STT3 markedly impedes the cell cycle in cervical carcinoma cells, inhibiting tumour proliferation while promoting apoptosis.• STT3 regulates...

Pan-Pan Yu, Yan Wei, Bo-Wen Diao et al. · 0 citations
Open access Sep 2026

CNTN5 Promotes Invasion and Metastasis in Non‐Small Cell Lung Cancer by Regulating YAP1 Nuclear Translocation

Non‐small cell lung cancer (NSCLC) is a leading cause of cancer‐related death worldwide, largely owing to its high metastatic potential. Contactin‐5 (CNTN5), a glycosylphosphatidylinositol‐anchored membrane protein, has been implicated in tumor‐related processes; however, its role in NSCLC progression remains unclear....

Jia-Rui Wang, Meng-Tao Wang, Yan-Ze Yin et al. · 0 citations
Open access Aug 2026

EZH1/2 inhibition selectively targets SMARCA4/2 co-deficient lung cancer cells by suppressing stemness and proliferation

Highlights • SMARCA4/2 co-deficient lung cancer cells share transcriptomic features with SMARCA4-UT.• The EZH1/2 inhibitor HM97662 selectively suppresses growth in SMARCA4/2-deficient cells.• HM97662 induces apoptosis and attenuates stemness marker expression selectively.• Broad PRC2 target derepression, but selective...

J. Lee, Jaeik Oh, Soyeon Kim et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.